Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 60.24 ($0.73) and traded as low as GBX 57 ($0.69). Tissue Regenix Group shares last traded at GBX 57.03 ($0.69), with a volume of 4,648 shares traded.
Tissue Regenix Group Trading Down 2.4 %
The company has a 50 day moving average of GBX 58.26 and a two-hundred day moving average of GBX 60.16. The stock has a market capitalization of £40.67 million, a PE ratio of -5,709.00 and a beta of 1.61. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- How to Choose Top Rated Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Stock Sentiment Analysis: How it Works
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
